Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting ...

Stevens Transport’s Cory Troxell is one of five military veteran rookie drivers in the running for the ninth annual contest’s grand prize—a Kenworth T680 sleeper truck. Justin Johnson ...

The Breakthrough Therapy designation is supported by positive interim data from the phase 2b VANTAGE study (ClinicalTrials.gov Identifier: NCT05050136) that evaluated the efficacy and safety of ...

Volixibat is an oral, minimally absorbed agent designed to selectively inhibit the ileal bile acid transporter (IBAT). Volixibat may offer a novel approach ... in Phase 2b studies for primary ...

Volixibat is an oral, minimally absorbed agent designed to selectively inhibit the ileal bile acid transporter (IBAT ... (VISTAS study), and primary biliary cholangitis (VANTAGE study).

Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company developing positive functional modulators (PFMs), small ...

These approaches show promise in pre-clinical and clinical studies, particularly in hepato-pancreato-biliary cancers with large unmet needs ... are also involved in regulating selectivity for ions and ...

Transport is vital to the well-functioning of economic activities and a key to ensuring social well-being and cohesion of populations. Transport ensures everyday mobility of people and is crucial to ...